Automated RNA extraction and DNA isolation technologies from QIAGEN

Michael Kazinski presents QIAGEN's comprehensive product range for DNA and RNA isolation from various biological samples including blood, cells, tissue, and environmental samples. He establishes QIAGEN's market leadership and explains the availability of both manual and automated solutions.

The speaker discusses how automation is becoming essential across all laboratory scales and introduces QIAGEN's two flagship automation instruments: the QIAsymphony and QIAcube Connect.

The QIAsymphony is presented as a flagship instrument with over 2,700 units sold worldwide. It features an easy-to-use interface, mag-bead-based technology with disposable prefilled cartridges, and allows continuous sample and reagent loading during operation.

The QIAcube Connect is highlighted as the only instrument capable of converting manual nucleic acid isolation processes into automated workflows without kit adaptation. This allows customers to transfer existing manual protocols directly to the automated system.

The QIAcube HT is introduced as a higher-throughput alternative, with both QIAcube instruments combined having sold over 8,000 units. These systems offer flexible operation and remote connectivity features for monitoring and control.

QIAGEN is presented as the most trusted brand in nucleic acid isolation, backed by extensive scientific validation including over 200,000 publications from laboratories worldwide and contributions from Nobel Prize winners.